Source: Eur Respir J , 49 (2) 1501924; DOI: 10.1183/13993003.01924-2015
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Xiaoping Long, Xuan He, Shinichiro Ohshimo, Matthias Griese, Rafael Sarria, Josune Guzman, Ulrich Costabel, Francesco Bonella. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis. Eur Respir J , 49 (2) 1501924; DOI: 10.1183/13993003.01924-2015

Member's Comments

No comment yet.

Related content which might interest you: Serum CC16 is a potential predictor for IPF diagnosis and prognosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 YKL-40 and KL-6 in serum and sputum samples of patients diagnosed with hypersensitivity pneumonitis. Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases Year: 2019 Serum KL-6 as a biomarker to assess risk of worse outcome in patients with SARS-CoV2 infection Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Levels of YKL-40 in serum and sputum of patients diagnosed with hypersensitivity pneumonitis: A pilot study. Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Clinical utility of CCL15 as a prognostic biomarker for hypersensitivity pneumonitis Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new? Year: 2019 Serum KL-6 elevation related with severity in patients with pneumocystis pneumonia Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011 The serum YKL-40 is a useful biomarker for asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Serum biomarkers in SSc-ILD: association with presence, severity and prognosis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Circulating fetuin-A as a biomarker predicting mortality in ICU septic patients Source: International Congress 2017 – Sepsis, infections, ARDS and beyond Year: 2017 The relationship between the serum YKL-40 level and severity of asthma Source: Annual Congress 2012 - Asthma management Year: 2012 Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis Source: Eur Respir J 2014; 43: 1530-1532 Year: 2014 Fibrinogen like the predictor of COVID-19 pneumonia progression Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Serum C-reactive protein (CRP) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP) Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 Factors predicting response to azathioprine in chronic hypersensitivity pneumonitis – the importance of BAL lymphocytosis Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 BAL neutrophilia as a predictor factor on IPF mortality Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Analysis of IgE and C-reactive protein as possible predictors of exacerbation patients with asthma Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 Is YKL-40 a prognostic marker in sarcoidosis? Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010